A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?

Uprichard J, Perry DJ (2002) Factor X deficiency. Blood Rev 16(2):97–110 ReviewCrossRefPubMedGoogle Scholar

Furie B, Greene E, Furie B (1977) Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X. N Engl J Med 297(2):81–85CrossRefPubMedGoogle Scholar

Coucke L, Trenson S, Deeren D, Van haute I, Devreese K (2013) Life-threatening bleeding tendency provoked by an acquired isolated factor X deficiency associated with respiratory infection. Ann Hematol 92(10):1437–1438CrossRefPubMedGoogle Scholar

Korte W, Flury R (1992) Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy. Ann Hematol 64:152–154CrossRefPubMedGoogle Scholar

Stefanini M, Wiggishoff CC (1966) Stuart factor (factor X) deficiency associated with renal and adrenal cortical insufficiency. Ann Intern Med 64:1285–1291CrossRefPubMedGoogle Scholar

Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A et al (2017) A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response. J Transl Med 15(1):150CrossRefPubMedPubMedCentralGoogle Scholar

Henson K, Files J, Morrison F (1989) Transient acquired factor X deficiency: report of the use of activated clotting concentrate to control a life-threatening hemorrhage. Am J Med 87(5):583–585CrossRefPubMedGoogle Scholar